1 study found for:    192076 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia
Condition: Lymphoproliferative Disorders
Intervention: Drug: Alemtuzumab (Campath)

Indicates status has not been verified in more than two years